[Drug-induced reversible cerebral vasoconstriction syndrome : Ustekinumab as possible trigger?]

Schmerz. 2020 Aug;34(4):350-353. doi: 10.1007/s00482-020-00479-5.
[Article in German]

Abstract

The reversible cerebral vasoconstriction syndrome (RCVS) is a common cause of thunderclap headache. Many trigger factors, such as the intake of vasoactive and less commonly immunosuppressive medication have previously been described. This article reports the first case of the occurrence of RCVS after the intake of ustekinumab in a female patient with a history of Crohn's disease.

Keywords: Crohn’s disease; Headache; Immunomodulation; Thunderclap headache; Vasospasm.

Publication types

  • Case Reports

MeSH terms

  • Dermatologic Agents* / adverse effects
  • Female
  • Headache Disorders, Primary*
  • Humans
  • Ustekinumab / adverse effects
  • Vasoconstriction
  • Vasospasm, Intracranial* / chemically induced

Substances

  • Dermatologic Agents
  • Ustekinumab